5-Fluorouracil Cardiotoxicity: Reversible Left Ventricular Systolic Dysfunction with Early Detection
Overview
Affiliations
A 33-year-old man presented to hospital with acute shortness of breath and evolving ST segment changes on ECG 3 days following a cycle of 5-fluorouracil (5-FU) for colon cancer. Despite no cardiac history, subsequent echocardiogram showed severe left ventricular systolic dysfunction. The patient was initially treated with heart failure medications and his coronary angiogram was normal. Chemotherapy was stopped and he was started on nitrates and calcium channel blockers. A repeat echocardiogram and cardiac MRI a week later showed complete resolution of his left ventricular dysfunction and he was discharged home. This case report summarises 5-FU cardiotoxicity, and emphasises the importance of early recognition and correct treatment, as left ventricular systolic dysfunction in this context is potentially reversible.
Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications.
Kwok C, Nolan M Front Cardiovasc Med. 2023; 10:1150569.
PMID: 37745115 PMC: 10516301. DOI: 10.3389/fcvm.2023.1150569.
PET Tracers for Imaging Cardiac Function in Cardio-oncology.
Kelly J, Babich J Curr Cardiol Rep. 2022; 24(3):247-260.
PMID: 35028820 PMC: 8934332. DOI: 10.1007/s11886-022-01641-4.
Li Y, Zhang Y, Zhou X, Lei X, Li X, Wei L Exp Ther Med. 2021; 22(6):1451.
PMID: 34721693 PMC: 8549097. DOI: 10.3892/etm.2021.10886.
Aleksova A, Gagno G, Pierri A, Todaro C, Fluca A, Orlando V Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34204714 PMC: 8231635. DOI: 10.3390/ph14060563.
Bikiewicz A, Banach M, von Haehling S, Maciejewski M, Bielecka-Dabrowa A ESC Heart Fail. 2021; 8(4):2397-2418.
PMID: 33955207 PMC: 8318493. DOI: 10.1002/ehf2.13365.